Research output per year
Research output per year
Personal profile
Education/Academic qualification
PhD, Circadian clock control of the endoplasmic reticulum unfolded protein response and influence on lipid metabolism in mice, Université de Montpellier
Award Date: 17 Dec 2010
Master, Modulation of lipid raft proteins following T cell activation, Université de Montpellier
Award Date: 1 Jul 2006
Keywords
- Q Science (General)
- immunology
- metabolism
- chronic lymphocytic leukemia
- T cells
- circadian rhythm
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 4 Article
-
Electron transport chain and mTOR inhibition synergistically decrease CD40 signaling and counteract venetoclax resistance in chronic lymphocytic leukemia
Chen, Z., Cretenet, G., Carnazzo, V., Simon-Molas, H., Kater, A. P., Windt, G. J. W. V. D. & Eldering, E., 1 Jan 2024, In: Haematologica. 109, 1, p. 151-162 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access3 Citations (Scopus) -
T-cell dysfunction by pseudohypoxia and autocrine purinergic signaling in chronic lymphocytic leukemia
Montironi, C., Jacobs, C. F., Cretenet, G., Peters, F. S., Schomakers, B. V., van Weeghel, M., Kater, A. P., Simon-Molas, H. & Eldering, E., 2023, In: Blood advances. 7, 21, p. 6540-6552 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access2 Citations (Scopus) -
Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment
Chen, Z., Simon-Molas, H., Cretenet, G., Valle-Argos, B., Smith, L. D., Forconi, F., Schomakers, B. V., van Weeghel, M., Bryant, D. J., van Bruggen, J. A. C., Peters, F. S., Rathmell, J. C., van der Windt, G. J. W., Kater, A. P., Packham, G. & Eldering, E., 11 Aug 2022, In: Blood. 140, 6, p. 630-643 14 p.Research output: Contribution to journal › Article › Academic › peer-review
16 Citations (Scopus) -
Combined ibrutinib and venetoclax treatment vs single agents in the TCL1 mouse model of chronic lymphocytic leukemia
Kater, A. P., Slinger, E., Cretenet, G., Martens, A. W., Balasubramanian, S., Leverson, J. D. & Eldering, E., 14 Dec 2021, In: Blood advances. 5, 23, p. 5410-5414 5 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access17 Citations (Scopus)